155
155
Oct 2, 2014
10/14
by
BLOOMBERG
tv
eye 155
favorite 0
quote 0
w glaxo and smith klein is currently testing a vaccine for ebola. great to have you with us. i wonder if you could describe how did glaxo smith kline become associated with this attempt to find a vaccine for ebola? >> of course. thank you. and it is a pleasure to be here. in 2013 we purchased a company called ocaris. they had an ebola vaccine in the works. so in august of this year once the ebola crisis became epic proportions, the world health organization came to us and asked if we would attempt to phase them into trials. >> so that's where it is now, phase one trials? >> that's correct. human trials to test for safety. >> what's the time-line for this trial? >> there are four trials happening concurrently. there are two in the u.s. being sponsored by nih. one also in oxford, england. two more trials are happening in west africa. we expect to get the data from the phase one trials to be completed by the end of this year. hopefully based on the data, we will go into phase two trials in early 2015. >> donna, just to give people an understanding of the kind of distribution net
w glaxo and smith klein is currently testing a vaccine for ebola. great to have you with us. i wonder if you could describe how did glaxo smith kline become associated with this attempt to find a vaccine for ebola? >> of course. thank you. and it is a pleasure to be here. in 2013 we purchased a company called ocaris. they had an ebola vaccine in the works. so in august of this year once the ebola crisis became epic proportions, the world health organization came to us and asked if we...
277
277
Oct 29, 2014
10/14
by
KDTV
tv
eye 277
favorite 0
quote 0
comenzarÁn las primeras pruebas de una vacuna experimental contra el Ébola de la empresa farmacÉutica glaxo mercado sus toallitas limpiadoras para bebÉ tras encontrar una bacteria que taca sistema inmunolÓgico. las marcas afectadas son cuties, members mark, sunny smile, y well benning. >> una cÁmara escondida muestra que lo que para unos son piropos puede ser para otros ♪ >> piensen esto una cÁmara escondida permitiÓ demostrar a una mujer atractiva caminando por una calle atrae generalmente piropos de admiradores del sexo opuesto. >> este camarÓgrafo se las ingenio para grabar 10 horas a una actriz en una calle de ny que la vestida normal y portaba un micrÓfono camuflado. >> el video ha generado miles de comentarios en internet algunas de crÍtica porque se trata de una campaÑa organizaciÓn que recauda fondos para combatir el acoso callejero. >> en este caso segÚen el video la mayorÍa fueron saludos no ofensivos aunque suman mÁs de 100 algo como 10 interacciones entre comillas por hora. >> el colmo. >> un hotel de londres tiene una oferta especial para los fanÁticos de harry potter. dormitor
comenzarÁn las primeras pruebas de una vacuna experimental contra el Ébola de la empresa farmacÉutica glaxo mercado sus toallitas limpiadoras para bebÉ tras encontrar una bacteria que taca sistema inmunolÓgico. las marcas afectadas son cuties, members mark, sunny smile, y well benning. >> una cÁmara escondida muestra que lo que para unos son piropos puede ser para otros ♪ >> piensen esto una cÁmara escondida permitiÓ demostrar a una mujer atractiva caminando por una calle...
41
41
Oct 21, 2014
10/14
by
ALJAZAM
tv
eye 41
favorite 0
quote 0
another vaccine developed by glaxo smith klein is based on a cold virus and is being tested in the united states and the u.k. results from that are expected before the end of the year. but ten thousand doses are being prepared to be sent to west africa if it's shown to be effective and safe. johnson and johnson is also developing a vaccine to be tested early next year. it requires two injections. one to prime the immune system and the other to boost it. the company says the vaccine can be manufactured quickly because every component can be produced separately. >>> quarantining ebola sufferers is still the most effective way to stop its spread but in west africa itself doing so means cutting off already poor people from their source of income. it's usually so busy here but now it's deserted. shops closed indefinitely and farmers who usually are here stay away. more than 20 homes in the town are cordened off under quarantine. all people lives in households where someone has died of ebola or had contact with a person confirmed as positive are required to stay inside their homes for 21 days.
another vaccine developed by glaxo smith klein is based on a cold virus and is being tested in the united states and the u.k. results from that are expected before the end of the year. but ten thousand doses are being prepared to be sent to west africa if it's shown to be effective and safe. johnson and johnson is also developing a vaccine to be tested early next year. it requires two injections. one to prime the immune system and the other to boost it. the company says the vaccine can be...
35
35
Oct 23, 2014
10/14
by
LINKTV
tv
eye 35
favorite 0
quote 0
i think lack so have a very clear plan to be one of the -- glaxo has a very clear plan to be one of theeaders, and it is important to demonstrate leadership they have in this product area. >> the pharmaceutical industry says it's important to have many vaccines in development, as it's not certain which ones will work. they have also said pulling -- pooling there be their resources together will help. >> the canadian prime minister said they will step up their fight against terrorism, this as they are hit with two potential terrorist attacks in three days. four blackwater employees could face decades in prison as they're convicted of murdering iraqis. in the murder -- and in mexico, the mayor and his wife are on the run, accusing the disappearance of 43 students. >> a company announced a bigger than forecast hole in its profits. they were off by some 330 million euros, that means pretax profit for the full year fell by 91.9%. and tesco shares made an equally dazzling fall over the past two months. during this time, tesco has lost more than 1/5 of its market value. the company was forced
i think lack so have a very clear plan to be one of the -- glaxo has a very clear plan to be one of theeaders, and it is important to demonstrate leadership they have in this product area. >> the pharmaceutical industry says it's important to have many vaccines in development, as it's not certain which ones will work. they have also said pulling -- pooling there be their resources together will help. >> the canadian prime minister said they will step up their fight against...
40
40
Oct 28, 2014
10/14
by
ALJAZAM
tv
eye 40
favorite 0
quote 0
. >>> glaxo-smith klein has received the green light to test the experimental ebola vaccine. some of those who will receive it are health workers headed for west africa where the virus has killed the largest number of people so far. it's based on a genetically modified chimp virus. >>> afghan president is in china right now. here's more from kabul. >>reporter: china is afghanistan's biggest business investor. thanks to a $3 billion deal for the rights to this copper-rich area outside kabul. but there are no chinese miners here. the roads and railways have not started. security concerns have stalled the project. in china, the president of afghanistan is hoping to revive this deal and chinese investment in his country's minerals worth annest meated $1 trillion. afghanistan wants chinese products. he travels to china once a year to buy goods shipped through neighboring pack stand. he hopes someday they'll arrive by truck. >> we can make a route from afghanistan directly to china. this is the first of what we need for the future. >>reporter: but the border is in a remote corner o
. >>> glaxo-smith klein has received the green light to test the experimental ebola vaccine. some of those who will receive it are health workers headed for west africa where the virus has killed the largest number of people so far. it's based on a genetically modified chimp virus. >>> afghan president is in china right now. here's more from kabul. >>reporter: china is afghanistan's biggest business investor. thanks to a $3 billion deal for the rights to this copper-rich...
52
52
Oct 24, 2014
10/14
by
ALJAZAM
tv
eye 52
favorite 0
quote 0
van seen by glaxo smith kline and new link working with canada. the most advanced and starting human trials. the next is to testify them in thousands of volunteers in liberia, sierra leone and guinea. five other experimental vaccines are in the pipeline including one by johnson and johnson which is looking to begin trials at the start of 2015. all of it being fast tracked because no ebola vaccine exists. >> the incentive for a pharmaceutical company to get involved in putting a major investment to develop a vaccine for a disease that up until this outbreak had less than 2500 people infected, we did not have the kind incentive saying on the part of industry, we certainly have that now. >> reporter: now johnson and johnson says it's talking with competitors on collaborate to go ramp up production, money to fight ebola is coming in from a wide range of sources from governments to cherries the e.u. is the latest to pledge $1.2 billion. but before drug companies proceed they want legal protection if there are adverse reaction to his vaccines. >> i do n
van seen by glaxo smith kline and new link working with canada. the most advanced and starting human trials. the next is to testify them in thousands of volunteers in liberia, sierra leone and guinea. five other experimental vaccines are in the pipeline including one by johnson and johnson which is looking to begin trials at the start of 2015. all of it being fast tracked because no ebola vaccine exists. >> the incentive for a pharmaceutical company to get involved in putting a major...
65
65
Oct 28, 2014
10/14
by
ALJAZAM
tv
eye 65
favorite 0
quote 0
. >>> drugs manufacturer glaxo smith kline has received the green light to test its ebola vaccine, 120 volunteers will receive the experimental vaccine in a hospital in switzerland some of those receiving it are health workers heading to west africa where the virus has killed the largest number of people so far. it's based on a genetically manufactured chimpanzee seen virus. >>> wall to wall coverage of the outbreak is being blamed for the growing hysteria over the disease. some believe it's being blown out of proportion and there are calls for greater perspective in how it's being reported. tom ackerman has more. >> reporter: as of last week, the number of this year's confirmed ebola cases worldwide stood at 10,141. killing 4,922 people. compare those numbers with four confirmed cases in the u.s. ending in just one death. none ofless, ebola fever, though not the physical sort, has been rising in america. >> this is something that everybody in the country is thinking about. >> reporter: 24 hour media coverage of every case suspected or actual, has elevated the anxiety. to the point tha
. >>> drugs manufacturer glaxo smith kline has received the green light to test its ebola vaccine, 120 volunteers will receive the experimental vaccine in a hospital in switzerland some of those receiving it are health workers heading to west africa where the virus has killed the largest number of people so far. it's based on a genetically manufactured chimpanzee seen virus. >>> wall to wall coverage of the outbreak is being blamed for the growing hysteria over the disease....
355
355
Oct 17, 2014
10/14
by
KYW
tv
eye 355
favorite 0
quote 2
. >> reporter: one potential vaccine was developed here at n.h., with a pharmaceutical company glaxo-smith-kline. human trials began last month. but, scott, even they're successful, the head of research at the company says a vaccine wouldn't be ready until 2016. >> pelley: juliana, thanks very much. another big story tonight-- bermuda is in the crosshairs of hurricane gonzalo. it is a powerful category 3. from space, it almost looks beautiful but on the ground, it's going to be an ugly picture. eric fisher, our chief meteorologist at our cbs boston station wbz is following this for us. eric. >> reporter: scott, the worst of hurricane gonzalo is impacting bermuda right now. northern eye wall is moving across the island, a category 3 storm, sustained winds at 115 miles per hour, but wind have been gusting over 120 miles per hour so far this evening. you see the circulation. the eye wall just starting to move in across the island, and waves up to 30 feet have been crashing ashore. those winds as well have knocked out power to more than half of the customers on bermuda so far this evening. so a dest
. >> reporter: one potential vaccine was developed here at n.h., with a pharmaceutical company glaxo-smith-kline. human trials began last month. but, scott, even they're successful, the head of research at the company says a vaccine wouldn't be ready until 2016. >> pelley: juliana, thanks very much. another big story tonight-- bermuda is in the crosshairs of hurricane gonzalo. it is a powerful category 3. from space, it almost looks beautiful but on the ground, it's going to be an...
142
142
Oct 15, 2014
10/14
by
BLOOMBERG
tv
eye 142
favorite 0
quote 0
. >> glaxo said it would in theory have 27,000 vaccines by december, today is october 15.e do for anybody who comes down with it over the next eight weeks? >> the best the cdc can do today is find out what lapses have taken place in the way the patient has been cared for. the nurse that had been infected said that she may remember touching her face after she was changing her protective gear. they have got to come down really hard on the way that they deal with suspected cases. it is the only way of containing it today. >> sam fazeli joining us from london, thank you. >> thank you to our producers for non-hysterical coverage of ebola. speaking of hysterical, lisa abramowicz with us. i want to talk about a word -- unconstrained. that is a none of my books. unm, help me here, what does constrained mean? do not followu particular benchmarks, so you give managers more freedom -- >> let me to find that -- go make money. fuss, one of my here he oes, they have been doing this for years and it is big bets, right? >> it is not clear. funds, unconstrained they are betting on smaller
. >> glaxo said it would in theory have 27,000 vaccines by december, today is october 15.e do for anybody who comes down with it over the next eight weeks? >> the best the cdc can do today is find out what lapses have taken place in the way the patient has been cared for. the nurse that had been infected said that she may remember touching her face after she was changing her protective gear. they have got to come down really hard on the way that they deal with suspected cases. it is...
7,224
7.2K
Oct 28, 2014
10/14
by
BLOOMBERG
tv
eye 7,224
favorite 0
quote 0
in april, it said it would abide abide -- buy would glaxo's cancer unit.report. what we are expecting to hear and investors is and adjust it net income of under $3 billion. the expectation in terms of $2.55 million. that's what people are expecting that are producing and in the last quarter. things to watch, how is it affecting and depreciating oil price? >> was it 5% or something? >> yeah. the following has been more -- fall has been more recent and would've to see the gulf of mexico fiasco. it is not over yet? we should get something new. grossly negligent. russian exposure, 20% of gross left -- rose left. it's always unpredictable and we'll have to see. the big question is a ruvell exposure and how they are doing in terms of production. that is one company that has been targeted by sanctions. >> you will speak to the russian billionaire behind tmk. more pipes that anyone. the chairman of the company is uniquely placed to look at the oil and gas industry and where we are now. in russia, they are the things provider of pipes. the question i had, we have a
in april, it said it would abide abide -- buy would glaxo's cancer unit.report. what we are expecting to hear and investors is and adjust it net income of under $3 billion. the expectation in terms of $2.55 million. that's what people are expecting that are producing and in the last quarter. things to watch, how is it affecting and depreciating oil price? >> was it 5% or something? >> yeah. the following has been more -- fall has been more recent and would've to see the gulf of...
40
40
Oct 29, 2014
10/14
by
BLOOMBERG
tv
eye 40
favorite 0
quote 0
earlier this year, they did a deal with glaxo, buying their oncology business, partnering with them toddress the business. this is the kind of stock we like at the moment. >> can they capitalize on the mess at santa fe? fi?-- at sanop sanofi was very important in the restructuring and the performance of sanofi. very strongome drugs. it is not just a question of the ceo. there will be a little period of uncertainty at sanofi that some might take advantage of. sanofit competitor to for insulin drugs, for example. beyond this uncertainty, the question will be, who will be the new ceo? >> i am very happy to have you here. you hawked facebook stock. facebook looking for a fourth quarter of growth. next year they are going to spend more. what i found fascinating is that we got a number that whatsapp delivers. they paid $19 million for the company. approvereholder, do you of that kind of spending? >> i think it is the wrong way to try to allocate revenues. if you look at google, which has been establishing its presence theobile, they did it via android system which was given for free. nobody
earlier this year, they did a deal with glaxo, buying their oncology business, partnering with them toddress the business. this is the kind of stock we like at the moment. >> can they capitalize on the mess at santa fe? fi?-- at sanop sanofi was very important in the restructuring and the performance of sanofi. very strongome drugs. it is not just a question of the ceo. there will be a little period of uncertainty at sanofi that some might take advantage of. sanofit competitor to for...
83
83
Oct 22, 2014
10/14
by
BBCAMERICA
tv
eye 83
favorite 0
quote 0
in the past hour, glaxo smith kline announced the bigger happen expected results.ear for competition of key drugs in the $500 million fine for bribery in china. gaxo smith kline says it will shake a up management and return nearly $6.5 billion to shareholders. also got this. the french oil giant has announced patrick, currently head of refining and chemicals will take over as chief executive following the death of the leader in the plane crash monday. the head of the company has named a new chairperson. russian experts said the plane crash that killed the leader and three others yesterday, the jet hit the snowplow. it was caused by criminal negligence. tweet me @bbc aaron. that's it with business. david, back to you. >>> the breaking news for you as has developed in the course of "gmt" today. the american jeffrey fowle who's been spending six months in custody in north korea has landed at an air base this ohio, a free man. he was reported to have been having left a bible in the toilet of a restaurant in north korea and detained when he tried to leave the country. t
in the past hour, glaxo smith kline announced the bigger happen expected results.ear for competition of key drugs in the $500 million fine for bribery in china. gaxo smith kline says it will shake a up management and return nearly $6.5 billion to shareholders. also got this. the french oil giant has announced patrick, currently head of refining and chemicals will take over as chief executive following the death of the leader in the plane crash monday. the head of the company has named a new...
263
263
Oct 29, 2014
10/14
by
KDTV
tv
eye 263
favorite 0
quote 0
comenzarÁn las primeras pruebas de una vacuna experimental contra el Ébola de la empresa farmacÉutica glaxostrar a una mujer atractiva caminando por una calle atrae generalmente piropos de admiradores del sexo opuesto. >> este camarÓgrafo se las ingenio para grabar 10 horas a una actriz en una calle de ny que la vestida normal y portaba un micrÓfono camuflado. >> el video ha generado miles de comentarios en internet algunas de crÍtica porque se trata de una campaÑa organizaciÓn que recauda fondos para combatir el acoso callejero. >> en este caso segÚen el video la mayorÍa fueron saludos no ofensivos aunque suman mÁs de 100 algo como 10 interacciones entre comillas por hora. >> el colmo. >> un hotel de londres tiene una oferta especial para los fanÁticos de harry potter. dormitorios que fueron transformados en cÁmaras de magia, estÁn decorados con botellas de pociones, velas, baÚles de viaje, ventanas gÓticas y cabezales de cama al estilo. >> grifindor. tambiÉn ofrece un paquete turÍstico con el autobÚs harry potter que conduce a los estudios warner para ver los escenarios de las pelÍculas.
comenzarÁn las primeras pruebas de una vacuna experimental contra el Ébola de la empresa farmacÉutica glaxostrar a una mujer atractiva caminando por una calle atrae generalmente piropos de admiradores del sexo opuesto. >> este camarÓgrafo se las ingenio para grabar 10 horas a una actriz en una calle de ny que la vestida normal y portaba un micrÓfono camuflado. >> el video ha generado miles de comentarios en internet algunas de crÍtica porque se trata de una campaÑa...
38
38
Oct 22, 2014
10/14
by
ALJAZAM
tv
eye 38
favorite 0
quote 0
one is tested by pharmaceutical giant glaxo smith klein, the other by canada's agency. >> quarantiningbola sufferers is an effective way. doing so means cutting off more people from their income. >> in junction in sierra leone is a busy trading hub. now it's deserted. shops are closed, and farmers that come to the town's market to sell fruit and vegetables are staying away. >> some people die because of hunger. because of poverty, not to ebola, no more. they are hungry. >> reporter: more than 20 homes in the town are cordoned off, under quarantine. all people lying in households where someone -- living in households where someone died or who have had contact with someone who is positive are required to stay in their homes for 21 days, a measure health officials hope will stop the virus spreading. it comes at a price. >> aid groups have been supplying food to some of those understand quarantine, for many who are poor, it's been a desperate time. alfred recovered from the virus, to find 12 of his family members had died. >>> in neighbouring liberia, the president fears ebola will result
one is tested by pharmaceutical giant glaxo smith klein, the other by canada's agency. >> quarantiningbola sufferers is an effective way. doing so means cutting off more people from their income. >> in junction in sierra leone is a busy trading hub. now it's deserted. shops are closed, and farmers that come to the town's market to sell fruit and vegetables are staying away. >> some people die because of hunger. because of poverty, not to ebola, no more. they are hungry....
720
720
Oct 24, 2014
10/14
by
WCAU
tv
eye 720
favorite 0
quote 15
researchers are testing two potential vaccines from glaxo smithkline and new link genetics. >>> countc 10 to help ease your concerns about the ebola virus. monday morning we'll have two medical professionals right here at the nbc 10 studios answering your questions. if you have a question, send it right now. logon to the nbc 10 facebook page and look for the ebola q & a section. >>> a philadelphia man will serve prison time for pleading guilty to placing an ad on craigslist for h omosexual sex. >>> new information tonight about a local lawmaker accused of using her elected office for political and financial gain. >> he's going to plead guilty to the charges. >> as of now, that's correct, yes. >> that's the attorney for leanna washington confirming to nbc 10's deanna durante that the pennsylvania state senator will plead guilty next week. he wouldn't say what the exact terms of the negotiated plea are. the 69-year-old democrat is facing felony charges for allegedly using her taxpayer paid staff to plan and perform political activities. washington lost her re-election bid in the may pri
researchers are testing two potential vaccines from glaxo smithkline and new link genetics. >>> countc 10 to help ease your concerns about the ebola virus. monday morning we'll have two medical professionals right here at the nbc 10 studios answering your questions. if you have a question, send it right now. logon to the nbc 10 facebook page and look for the ebola q & a section. >>> a philadelphia man will serve prison time for pleading guilty to placing an ad on...
450
450
Oct 17, 2014
10/14
by
BBCAMERICA
tv
eye 450
favorite 0
quote 0
and canada, but the british pharmaceutical company glaxo smith klein has told the bbc that the vaccineen developing won't be fully ready for at least a year. and it will not be the solution to the current outbreak. simon cox went to the gsk lab to find out why. >> reporter: try as they might to stop its spread, ebola still has the upper hand. some experts believe the only way to contain it is with a vaccine. gsk is one of the companies fast-tracking an ebola vaccine, trying to shrink ten years of development into one. but they warn it still won't be ready in time to solve the current outbreak. >> we have to have data on its efficacy. that will not be available until after the end of 2015. we have to be able to make doses consistent with general use and that's going to take well into 2016 to be able to do that. so unfortunately it's not going to be as quickly as we would like. >> trials have already begun with volunteers receiving the drug, but there are no guarantees it will work. the next stage of testing is to offer 20,000 doses of the vaccine to health workers in the new year. until
and canada, but the british pharmaceutical company glaxo smith klein has told the bbc that the vaccineen developing won't be fully ready for at least a year. and it will not be the solution to the current outbreak. simon cox went to the gsk lab to find out why. >> reporter: try as they might to stop its spread, ebola still has the upper hand. some experts believe the only way to contain it is with a vaccine. gsk is one of the companies fast-tracking an ebola vaccine, trying to shrink ten...
125
125
Oct 16, 2014
10/14
by
BBCAMERICA
tv
eye 125
favorite 0
quote 0
so is the reality also then that for the likes of glaxo-smith cline involved in these trials that it simply wasn't a profitable proposition to try and work out a vaccine? >> yes. before this outbreak, the target population in the market, if you will, was extremely, extremely limited. it was largely what we call in the u.s. a biodefense vaccine. for a highly lethal disease that was a problem in theory if nefarious individuals would deliberately cause a release of this. this is something we very much worried about in the decade after the events of september 11th, 2001, and the anthrax episodes that followed thereafter. scientists who work in the laboratory with ebola were one target population. small numbers of health care workers who would be a s.w.a.t. team, the type of individuals who previously brought the -- and world health organization individuals who brought the previous mini epidemics under control, they were another target population. but mass immunization and large number of individuals, that was not really on the docket. if there are very few numbers in the target populatio
so is the reality also then that for the likes of glaxo-smith cline involved in these trials that it simply wasn't a profitable proposition to try and work out a vaccine? >> yes. before this outbreak, the target population in the market, if you will, was extremely, extremely limited. it was largely what we call in the u.s. a biodefense vaccine. for a highly lethal disease that was a problem in theory if nefarious individuals would deliberately cause a release of this. this is something we...
77
77
Oct 21, 2014
10/14
by
ALJAZAM
tv
eye 77
favorite 0
quote 0
another vaccine developed by glaxo-smith-kline and this is tested in the u.s.and results by the end of the year. 10,000 dozes prepared to be sent to west africa if it is shown to be effective and safe and johnson and johnson has a virus and requires two injections one to prime and one to boost. it can be manufactured quickly because each component can be produced separately. while those drugs are being tested quarantine of ebola sufferers is the best way to stop it from spreading but it means cutting off already poor people from their sources of income as we report. >> reporter: junction and central sierra leone is usually a busy trading hub but now it's deserted. shops are closed indefinitely and farmers that usually come to the town's market to sell their fruit and vegetables are staying away. >> because of hunger and they die because of poverty. not to ebola. they are angry. >> reporter: more than 20 homes in the town are quarantined off under quarantine and all people in households where somebody has dade with ebola or someone who has had contact with a per
another vaccine developed by glaxo-smith-kline and this is tested in the u.s.and results by the end of the year. 10,000 dozes prepared to be sent to west africa if it is shown to be effective and safe and johnson and johnson has a virus and requires two injections one to prime and one to boost. it can be manufactured quickly because each component can be produced separately. while those drugs are being tested quarantine of ebola sufferers is the best way to stop it from spreading but it means...
95
95
Oct 15, 2014
10/14
by
FBC
tv
eye 95
favorite 0
quote 0
another effort going on at the national institute of health, cooperation with glaxo smith kline, very close in maryland. they're working i vaccine. not raising one another, but trying to get this out as quickly as possible. melissa: the united nations it turns out would agree. the head of the u.n. ebola emergency response says the world has 60 days to get this situation under control or face an unprecedented situation. the former director of pediatric neurosurgery at john hopkins hospital and a fox news contributor and he joins me now. thank you for joining us. what does that mean? we have 60 days to stop this, what does it look like to have stopped it? >> they are just recognizing the exponential potential of this thing to spread. like if you take two and multiply it by two, you keep doing that it does not take long to get into some very large numbers. they are just being realistic. we have known for a long time it has had this kind of potential. that is the reason several weeks ago i said it was a real mistake to bring infected people into this country in any way. not because we don
another effort going on at the national institute of health, cooperation with glaxo smith kline, very close in maryland. they're working i vaccine. not raising one another, but trying to get this out as quickly as possible. melissa: the united nations it turns out would agree. the head of the u.n. ebola emergency response says the world has 60 days to get this situation under control or face an unprecedented situation. the former director of pediatric neurosurgery at john hopkins hospital and a...
239
239
Oct 22, 2014
10/14
by
WHYY
tv
eye 239
favorite 0
quote 1
two companies, glaxo smith kline and johnson & johnson said today they're discussing a possible collaboration ifill: the government's latest steps illustrate again just how much anxiety remains about the prospect of ebola's spread. but as public health officials continue to emphasize, the real risk to most americans remains small. in fact, there are a number of other illnesses that continue to pose bigger threats. we outlined some of those concerns online and it attracted a great deal of public interest. so we decided to provide that context on our broadcast as well. hari sreenivasan recorded this conversation in our new york studios. >> sreenivasan: to get more information and perspective on this now from dr. william shaffner, an infectious disease expert joining us from nashville. first off, there were quite a few cases we heard out a few months ago about enterovirus d-68. this was something that was discovered in the '60s, but this is really first outbreak that we've had. yeah, hari, it's a very large outbreak. it's run across the entire country. children, many of them, have been affected.
two companies, glaxo smith kline and johnson & johnson said today they're discussing a possible collaboration ifill: the government's latest steps illustrate again just how much anxiety remains about the prospect of ebola's spread. but as public health officials continue to emphasize, the real risk to most americans remains small. in fact, there are a number of other illnesses that continue to pose bigger threats. we outlined some of those concerns online and it attracted a great deal of...
495
495
Oct 26, 2014
10/14
by
KYW
tv
eye 495
favorite 0
quote 6
one of the organizations glaxo is producing a vaccine now in numbers. they are starting clinical trials in people. hopefully earl any 2015, it will be fun to be effective and safe so they can try it but we're still ways off. >> why has it taken so long to develop when there have been so many cases in west africa already. >> so that ace great point. they have known about this for a while. vaccine development started many years ago but because it wasn't a priority, it was not funded presently but now that there is an urgency, emergency in the special area of the country now they are starting to really do it quickly because more money is put in and it is a priority. unfortunately it wasn't priority before. >> real quickly in just about 15 seconds left, are we making too big of a deal with this or are we right on point in our country there is in need to panic n developed countries with medical care is there no need to panic. the reason why we got behind the curve we didn't send in personnel early n those three affected country they spend less than a hundred
one of the organizations glaxo is producing a vaccine now in numbers. they are starting clinical trials in people. hopefully earl any 2015, it will be fun to be effective and safe so they can try it but we're still ways off. >> why has it taken so long to develop when there have been so many cases in west africa already. >> so that ace great point. they have known about this for a while. vaccine development started many years ago but because it wasn't a priority, it was not funded...
73
73
Oct 22, 2014
10/14
by
BLOOMBERG
tv
eye 73
favorite 0
quote 0
glaxo one of the businesses in were today concerned about the growth is coming from for this business seen it is going to a lackluster growth for a couple it gets rid of some of it. they need to do cost-cutting. nothing on the horizon in the next couple years. what you are looking at is a pretty boring, stable company, but it needs to reduce the costs and have lower difficulty in china and elsewhere. some of those are not clearing away. we have a new chairman and so on. >> they were not boring. stable and boring can be good if it is dividends you look after. >> there is sufficient cash flow coming in to support the dividends. int is where the uncertainty the marketplace has been. there has been enough people saying the dividend is under threat. i think that is cautious in terms of cuts. i think we will be ok for now. >> you had me running for my hardhat. i would take stability over the chaos. you said there were some large cap industries. an idea of what the industry groups are, and why should we take the risk if there is chaos ahead? oni think we should focus indices that are able to
glaxo one of the businesses in were today concerned about the growth is coming from for this business seen it is going to a lackluster growth for a couple it gets rid of some of it. they need to do cost-cutting. nothing on the horizon in the next couple years. what you are looking at is a pretty boring, stable company, but it needs to reduce the costs and have lower difficulty in china and elsewhere. some of those are not clearing away. we have a new chairman and so on. >> they were not...
91
91
tv
eye 91
favorite 0
quote 0
glaxo smith kline and new links genetics. working with the national institute of health.r, they want a vaccine to be delivered to the health care workers to protect them, that is where it is going first. those two stocks are for health care workers. >> there's a lot of buzz on wall street about a certain stock that seems to be effective. stuart: those of the ones with effective treatments. those are treatment stocks. liz: correct. interestingly enough the unit of fujifilm holdings appears to be having an effective treatment as well. the governments will probably ramp up spending to fight against evil a the prior estimate $600 million so a lot of money pointed at biotech companies possibly. so we will give you the developments as they come in. stuart: a lot of coverage all day long on the fox business network. today william fisher spent three weeks in africa trading real patients. they talked to the ceo of new links genetics. proceeding with trials of the vaccine. launching a new program today called uber militated great 15,000 jobs for military and spouses over the next 1
glaxo smith kline and new links genetics. working with the national institute of health.r, they want a vaccine to be delivered to the health care workers to protect them, that is where it is going first. those two stocks are for health care workers. >> there's a lot of buzz on wall street about a certain stock that seems to be effective. stuart: those of the ones with effective treatments. those are treatment stocks. liz: correct. interestingly enough the unit of fujifilm holdings appears...
102
102
Oct 9, 2014
10/14
by
BLOOMBERG
tv
eye 102
favorite 0
quote 0
>> there are quite a few companies in the u.s., glaxo in and fujifilm, which he do not normally see associatedhave been people developing drugs. the human cost of this is something we cannot measure. and we cannot ignore. there have to be drugs being developed. is potentially bringing out the human face of the drug industry. if you want to look at the other aspect, how much money could you get out of this current situation. one parallel would be what happened with the smallpox risk the u.s. was worrying about from a bioterrorism perspective. $800 million contract out for smallpox vaccines. aat is being shared between variety of companies. that is the magnitude, from a monetary perspective, we could reward to at for a some of these companies taking the risks to develop these drugs. >> in terms of the governments spending my, now that it is starting to ripple around the world, we have a nurse being tested in australia. has got to spend money? which companies and governments are going to be spending money on making sure their populations are protected? toagain i take you back smallpox. a much ris
>> there are quite a few companies in the u.s., glaxo in and fujifilm, which he do not normally see associatedhave been people developing drugs. the human cost of this is something we cannot measure. and we cannot ignore. there have to be drugs being developed. is potentially bringing out the human face of the drug industry. if you want to look at the other aspect, how much money could you get out of this current situation. one parallel would be what happened with the smallpox risk the...
51
51
Oct 21, 2014
10/14
by
CSPAN2
tv
eye 51
favorite 0
quote 0
. >> we have a question from a doctor in the audience reports from who and glaxo smithkline indicate the likelihood that the epidemic will be over before the vaccine to be licensed for efficacy this been a guy cannot comment on someone else's pronouncement i did not hear that but if that was said i would say right now i do think we can predict when the epidemic will be over it is still escalating as opposed to declining. so it is not very prudent to predict when it will end i think the best way is to make sure that we as a global community put in sufficient resources. >> is their concern about the blood supply at all? now here in america? >> in this country? >> i think at this point there are few cases that can be clearly identified and is not with blood donors i know the fda will keep an eye on this. >> how important in the media's role is? what can the media do better? >> and our area is has done a good job and a critical role to tell the facts there so many rumors how hard it is to be transmitted in a casual setting but the a break is a beer in west africa to work together. it is
. >> we have a question from a doctor in the audience reports from who and glaxo smithkline indicate the likelihood that the epidemic will be over before the vaccine to be licensed for efficacy this been a guy cannot comment on someone else's pronouncement i did not hear that but if that was said i would say right now i do think we can predict when the epidemic will be over it is still escalating as opposed to declining. so it is not very prudent to predict when it will end i think the...
66
66
tv
eye 66
favorite 0
quote 0
. >> much like glaxo is working on a vaccine so as they work on these vaccines it turns out they areaving to close all the findings, do all the trials, do them fast, faster than you ever would have thought. this is a rush job at its best. it looks like these particular vaccines may not be available until the first quarter of 2015. do you know the cdc warned that the number of infections could rise up to 1.4 million people by early next year without treatment? 3,000, roughly 3,000 died, 6500 have been infected, 1.4 million, humongous. stuart: we are talking the availability of treatment and vaccine. it is there? is it available? nicole: sounds like they're trying to get it through, they need regulatory approval and to do this in a safe manner and they need intended products that they want so that is what we are watching, you have other ones that run up 50% in the last three weeks, that is what we have been following and that is the story. we have a lot of names, five or six names in this group working on fighting ebola. stuart: tell me about the airline's? they were down yesterday. an
. >> much like glaxo is working on a vaccine so as they work on these vaccines it turns out they areaving to close all the findings, do all the trials, do them fast, faster than you ever would have thought. this is a rush job at its best. it looks like these particular vaccines may not be available until the first quarter of 2015. do you know the cdc warned that the number of infections could rise up to 1.4 million people by early next year without treatment? 3,000, roughly 3,000 died,...
160
160
Oct 24, 2014
10/14
by
CNBC
tv
eye 160
favorite 0
quote 0
i know glaxo. i did speak with the quintile's guy. he said forget it.he vaccine will take a long time. don't think anything is going to happen overnight. >> they are trying to compress what takes years. paul allen donated $100 million to the state department for containment of the evacuation of health care workers. >> that is so great. >> back to where we started on travel. american airlines which had incredible numbers. >> unbelievable quarter. >> up another 2% plus. >> they just coin money at these prices. i've got to get in that airline business. >> we are getting breaking news on this chiquita story. >> chiquita shareholders in a special meeting rejected the company's proposed merger with fyffes, an irish produce companies. chiquita brand shares up on the news here. they are going to terminate transaction agreements with fyffes and start discussions with the cutrale/safra groups. their current offer on the table is $14.50 per share. back to you. >> let's get to bob pisani with the dow up almost 53. >> a different reaction than we would have had a fe
i know glaxo. i did speak with the quintile's guy. he said forget it.he vaccine will take a long time. don't think anything is going to happen overnight. >> they are trying to compress what takes years. paul allen donated $100 million to the state department for containment of the evacuation of health care workers. >> that is so great. >> back to where we started on travel. american airlines which had incredible numbers. >> unbelievable quarter. >> up another 2%...
143
143
Oct 22, 2014
10/14
by
CNBC
tv
eye 143
favorite 0
quote 0
. >> and now people are watching j&j this morning and glaxo and the degree to which a vaccine can be developed. >> i had the company that does all the testing. that's letter q. let's calm down on this. many, many months. i would never if i were in a hedge fund buy this stock off this. the trials are going to be very extended. the fda is clearly fast tracking. everyone is fast tracking. everyone is going nuts to do it. you still have to try a vaccine on people before you see it work. here's a shot, go into that tent. you don't need to hazmat. so people stop trading off this. the actual process of getting something approved is not going to be suspended. even for the people who are deathly ill, they're not going to suspend it for the people them who actually have it. so stop trading off the idea that tomorrow the fda is going to bless something. >> finally, let's circle back to yahoo!. this is going to be a 4% day. breaking out mobile revenue for the first time. >> mobile is going to be over $1 billion. this is one of those calls that just said, you know what, you think i'm really stupi
. >> and now people are watching j&j this morning and glaxo and the degree to which a vaccine can be developed. >> i had the company that does all the testing. that's letter q. let's calm down on this. many, many months. i would never if i were in a hedge fund buy this stock off this. the trials are going to be very extended. the fda is clearly fast tracking. everyone is fast tracking. everyone is going nuts to do it. you still have to try a vaccine on people before you see it...
145
145
Oct 1, 2014
10/14
by
CNBC
tv
eye 145
favorite 0
quote 0
. >> glaxo. johnson & johnson downgraded today, incorrectly, i thought. but they're working on mass production. one of the reasons i don't want to speculate on tech miro, if you want mass production, it's going to have to come from companies like merck. these companies, by the way, they do have an element to them, let's not forget, of just giving the stuff. great american companies that have not thinking about how to make money. they're not mercenaries. >> okay. i got to make a phone call. >> got to make a phone call? >> all right. >> fannie and freddie. there's a lot going on. >> i got to make some calls. >> right during the break, let's all make some calls. when we come back, signs that the standoff between amazon and disney could be nearing an end. also, maynard webb live in an exclusive. we'll be right back. having a fe checked bag. with my united mileageplus explorer card. i have saved $75 in checked bag fees. priority boarding is really important to us. you can just get on the plane and relax. i love to travel, no foreign transaction fees means real
. >> glaxo. johnson & johnson downgraded today, incorrectly, i thought. but they're working on mass production. one of the reasons i don't want to speculate on tech miro, if you want mass production, it's going to have to come from companies like merck. these companies, by the way, they do have an element to them, let's not forget, of just giving the stuff. great american companies that have not thinking about how to make money. they're not mercenaries. >> okay. i got to make a...
113
113
Oct 4, 2014
10/14
by
KRON
tv
eye 113
favorite 0
quote 0
. >> : glaxo in california were gonna talk about the northern part of staten selling car the state might be like two different space with singularities we thought was to live in northern california living bus and the best place to live. again it was with nonself with a lot of fun talk to travel enthusiast of going down there what with the time. this week weather is very similar. >> : they're hot down there as well. always a little animosity between north and south. for this reason they come and buses also green things collette as part about it for us a minor worry if you caught on a plan be there quickly >> : born brothers were like about where brothers and you can get the best of all hollywood. different every day movies are shooting television show's shooting you never know where to run into. macy if there is story may see a story forgot about for a while and might say state of the to the movie offers the education side hollywood which is really nice along with the possibility to rugby star struck and and that >> : sounds ever for universal to where this is a lot of explosions monsters
. >> : glaxo in california were gonna talk about the northern part of staten selling car the state might be like two different space with singularities we thought was to live in northern california living bus and the best place to live. again it was with nonself with a lot of fun talk to travel enthusiast of going down there what with the time. this week weather is very similar. >> : they're hot down there as well. always a little animosity between north and south. for this reason...
155
155
Oct 6, 2014
10/14
by
CNNW
tv
eye 155
favorite 0
quote 0
we have a full cooperation with glaxo smith-kline.is is a vaccine we did the fundamental science on. they are closely involved with us, manufacturing it. when we prove that it works, they will be manufacturing it at a high levels to make it available. you have to prove it works first before you make tens of millions of doses. so there is not a problem with the vaccine vis-a-vis the organization. we have a strong collaboration with cline. >> we heard the dr. frieden say there is not z-map left. there is none to give the nbc cameraman or the man in dallas? >> right now. there is no za z-map. for sure. seven people received it. two of which dr. brantley and miss writeboll. they are all out of doses. the federal government, hhs, in part, due to the baudeer. the biomed cal advanced research. they are helping the company to get the resources to scale up the manufacture. they're right now manufacturing additional lots. it probably won't be ready for a month-and-a-half, two months. there are other experimental trucks in the true experimental
we have a full cooperation with glaxo smith-kline.is is a vaccine we did the fundamental science on. they are closely involved with us, manufacturing it. when we prove that it works, they will be manufacturing it at a high levels to make it available. you have to prove it works first before you make tens of millions of doses. so there is not a problem with the vaccine vis-a-vis the organization. we have a strong collaboration with cline. >> we heard the dr. frieden say there is not z-map...
288
288
Oct 27, 2014
10/14
by
CNBC
tv
eye 288
favorite 0
quote 0
i mean, obviously j & j and glaxo are pursuing vaccines.ies that you've talked a lot about on the air like mtekmira. i think they have taken significant steps to ensure that this is managed and i'm pretty confident that that will be the case. >> yeah. i hope so. and then i never know what to think of the notion that when we live here and we have, you know, new york city with 9 million people and we hear that, well, it's more torrent to deal with it in west africa than to worry about it getting in new york, is that really -- that argument really hold merit? that we can't make it difficult for aid orkers to get there, that would make it worse. we just need to stop it from getting on these shores is the knee jerk reaction. >> i think you have to do both, right? obviously people are going to be vigilant here. i think we will keep this under control here. by the same token, it has to be managed at its source. that has to be aggressively done. it's not object just keeping that from seeping out of there, but to obviously manage it in africa as agg
i mean, obviously j & j and glaxo are pursuing vaccines.ies that you've talked a lot about on the air like mtekmira. i think they have taken significant steps to ensure that this is managed and i'm pretty confident that that will be the case. >> yeah. i hope so. and then i never know what to think of the notion that when we live here and we have, you know, new york city with 9 million people and we hear that, well, it's more torrent to deal with it in west africa than to worry about...
183
183
Oct 3, 2014
10/14
by
CNBC
tv
eye 183
favorite 0
quote 0
vaccines are being worked on at glaxo smith klein. the patient is in serious condition.ecting an update later today in the news briefing. >> thank you very much. meg tir rel will bring us updates as we know more. >>> the national manufacturers association is kicking off its third annual manufacturing day today. president obama will be at the millennium steel plant in indiana. joining us right now first on cnbc is doug oberhelm. and joining us is jay timmons. welcome to both of you. it's great to see you. >> great to see you and good morning. we are celebrating today around the country and certainly here in washington with the nam board meeting. >> so the national manufacturers day. this is a day where what happens? you're trying to say these are great jobs. jay? >> opening their doors all over their countries. opening their doors to students and young people to show them all the possibilities that exist in manufacturing. there are still 600,000 jobs in manufacturing in this country that are open. we need people with the right skills to fill those jobs. >> i know the aver
vaccines are being worked on at glaxo smith klein. the patient is in serious condition.ecting an update later today in the news briefing. >> thank you very much. meg tir rel will bring us updates as we know more. >>> the national manufacturers association is kicking off its third annual manufacturing day today. president obama will be at the millennium steel plant in indiana. joining us right now first on cnbc is doug oberhelm. and joining us is jay timmons. welcome to both of...
236
236
Oct 7, 2014
10/14
by
CNBC
tv
eye 236
favorite 0
quote 1
we're joining by glaxo's chairman of vaccines.hank you so much for joining us. >> thank you for having me. good morning, everyone. >> it would be wonderful if you could walk us through where you are in development of your vaccine. we hear timelines like ten years to develop a vaccine. given the scope of the outbreak in africa, you're accelerating that. tell us how soon it could be developed. >> a vaccine usually takes between 10 to 30 years to go to being available approved for human use. the ebola vaccine program started about six years ago in a company based in italy. we acquired about 18 months ago. and we are currently running the first clinical trials, phase one clinical trials as well as scaling up the manufacturing process to be able to produce a bit more than what we can today. because it's just a new program. today we're about to produce about 10,000 doses every month using the manufacturing style. and we have experienced in a handful of individuals, human volunteers, that are testing the vaccine, we hope to be able withi
we're joining by glaxo's chairman of vaccines.hank you so much for joining us. >> thank you for having me. good morning, everyone. >> it would be wonderful if you could walk us through where you are in development of your vaccine. we hear timelines like ten years to develop a vaccine. given the scope of the outbreak in africa, you're accelerating that. tell us how soon it could be developed. >> a vaccine usually takes between 10 to 30 years to go to being available approved...
510
510
Oct 12, 2014
10/14
by
FOXNEWSW
tv
eye 510
favorite 0
quote 0
. >> one more question on the vaccine, glaxo smith klein working on this thing, 10,000 viles right nows. they are rushing it to market as fast as they can. >> it's 100% effective in primates. they gave it to 20 people in phase one. it looks good and is getting ready to go to phase two. it is probably about six months away from use in everybody, the large scale use. i think it's a ticket and could be a game-changer. >> dr. siegal, great to see you. >> great to see you. >>> other stories making headlines this sunday morning, we start with the fox news alert breaking overnight. baghdad under siege. news of a triple homicide bombing just outside the iraqi capital. at least 22 people are dead and dozens more injured in a kurdish security compound northeast of the city of diyala. a homicide bomber set off a bomb at the entrance and two more explosives were in cars driven into the come pound. this as militants aim for the capital and to compromise the baghdad airport. >> i don't know how to make it clearer, if the airport falls to isis, it's game over. iraq no longer exists as a viable countr
. >> one more question on the vaccine, glaxo smith klein working on this thing, 10,000 viles right nows. they are rushing it to market as fast as they can. >> it's 100% effective in primates. they gave it to 20 people in phase one. it looks good and is getting ready to go to phase two. it is probably about six months away from use in everybody, the large scale use. i think it's a ticket and could be a game-changer. >> dr. siegal, great to see you. >> great to see you....